UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II Trial

Stroke (1970), 2022-09, Vol.53 (9), p.STROKEAHA121037006-2729

2022

Link zum Volltext

Verfügbarkeit prüfen

The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke

PloS one, 2013-07, Vol.8 (7), p.e66960-e66960

2013

Link zum Volltext

Verfügbarkeit prüfen

Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure

PloS one, 2018-08, Vol.13 (8), p.e0201160

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans

Circulation (New York, N.Y.), 2011-05, Vol.123 (17), p.1891-1899

2011

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Overexpression of the Norepinephrine Transporter Uptake-1 Results in Marked Improvement of Heart Failure

Circulation research, 2005-10, Vol.97 (9), p.928-936

2005

Link zum Volltext

Verfügbarkeit prüfen

Generation of Functional Culture–Derived Platelets From CD34+ Progenitor Cells to Study Transgenes in the Platelet Environment

Circulation research, 2004-09, Vol.95 (5), p.e36-e44

2004

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of sympathetic nerve terminals with [11C]epinephrine and [11C]hydroxyephedrine and positron emission tomography

Circulation (New York, N.Y.), 2000-02, Vol.101 (5), p.516-523

2000

Link zum Volltext

Verfügbarkeit prüfen

Functional alterations after cardiac sodium-calcium exchanger overexpression in heart failure

American journal of physiology. Heart and circulatory physiology, 2006-08, Vol.291 (2), p.H488-H495

2006

Link zum Volltext

Verfügbarkeit prüfen

Na+/Ca2+ exchanger overexpression impairs frequency- and ouabain-dependent cell shortening in adult rat cardiomyocytes

American journal of physiology. Heart and circulatory physiology, 2004-10, Vol.287 (4), p.H1435-H1445

2004

Link zum Volltext

Verfügbarkeit prüfen

Retroviral infection and selection of culture-derived platelets allows study of the effect of transgenes on platelet physiology ex vivo and on thrombus formation in vivo

Arteriosclerosis, thrombosis, and vascular biology, 2005-08, Vol.25 (8), p.1750

2005

Link zum Volltext

Verfügbarkeit prüfen

The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times

PloS one, 2013-08, Vol.8 (8), p.e71193

2013

Link zum Volltext

Verfügbarkeit prüfen

Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance

Clinical Reviews in Allergy & Immunology, 2017-04, Vol.52 (2), p.182-193

2017

Link zum Volltext

Verfügbarkeit prüfen

Myocardial Technetium-99m-Tetrofosmin and Technetium-99m-Sestamibi Kinetics in Normal Subjects and Patients with Coronary Artery Disease

The Journal of nuclear medicine (1978), 1997-03, Vol.38 (3), p.428-432

1997

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of isoform 1 of the sarcoplasmic reticulum Ca(2+)-release channel in failing human heart

Circulation (New York, N.Y.), 2001-06, Vol.103 (22), p.2739-2744

2001

Link zum Volltext

Verfügbarkeit prüfen

SERCA2a activity correlates with the force-frequency relationship in human myocardium

American journal of physiology. Heart and circulatory physiology, 2000-06, Vol.278 (6), p.H1924-H1932

2000

Link zum Volltext

Verfügbarkeit prüfen

The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia

Scientific reports, 2020-12, Vol.10 (1), p.21420-21420, Article 21420

2020

Link zum Volltext

Verfügbarkeit prüfen

Cyclic Peptides for Effective Treatment in a Long-Term Model of Graves Disease and Orbitopathy in Female Mice

Endocrinology (Philadelphia), 2017-07, Vol.158 (7), p.2376-2390

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells

Molecular pharmacology, 2013-07, Vol.84 (1), p.25-40

2013

Link zum Volltext

Verfügbarkeit prüfen

Prolonged TSH Receptor A Subunit Immunization of Female Mice Leads to a Long-Term Model of Graves' Disease, Tachycardia, and Cardiac Hypertrophy

Endocrinology (Philadelphia), 2015-04, Vol.156 (4), p.1577-1589

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of glycoprotein VI and platelet adhesion on atherosclerosis—A possible role of fibronectin

Journal of molecular and cellular cardiology, 2010-09, Vol.49 (3), p.532-542

2010

Link zum Volltext

Verfügbarkeit prüfen

The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR -/- /ApoBec -/- Mice

Cellular physiology and biochemistry, 2019, Vol.52 (4), p.681-695

2019

Link zum Volltext

Verfügbarkeit prüfen

ADPase CD39 Fused to Glycoprotein VI‐Fc Boosts Local Antithrombotic Effects at Vascular Lesions

Journal of the American Heart Association, 2017-08, Vol.6 (8), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemiaa

TH open : companion journal to thrombosis and haemostasis, 2023-10, Vol.7 (4), p.e289-e293

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of the oxLDL Binding Protein Fc-CD68 on Plaque Extension and Vulnerability in Atherosclerosis

Circulation research, 2011-03, Vol.108 (6), p.695-703

2011

Link zum Volltext

Verfügbarkeit prüfen

PET/CT and MR imaging biomarker of lipid-rich plaques using [64 Cu]-labeled scavenger receptor (CD68-Fc)

International journal of cardiology, 2014-11, Vol.177 (1), p.287-291

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Englisch
(79)
Japanisch
(16)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(46)
Humans
(43)
Animals
(32)
Cardiovascular System & Cardiology
(30)
Cardiac & Cardiovascular Systems
(22)
Biological And Medical Sciences
(21)
Mice
(20)
Medical Sciences
(18)
Peripheral Vascular Disease
(17)
Female
(16)
Male
(16)
Cardiology. Vascular System
(12)
Glycoprotein Vi
(12)
Adult
(11)
Atherosclerosis
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Heart Failure
(10)
Hematology
(10)
Platelets
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II Trial

The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke

Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure

Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans

Cardiac Overexpression of the Norepinephrine Transporter Uptake-1 Results in Marked Improvement of Heart Failure

Generation of Functional Culture–Derived Platelets From CD34+ Progenitor Cells to Study Transgenes in the Platelet Environment

Evaluation of sympathetic nerve terminals with [11C]epinephrine and [11C]hydroxyephedrine and positron emission tomography

Functional alterations after cardiac sodium-calcium exchanger overexpression in heart failure

Na+/Ca2+ exchanger overexpression impairs frequency- and ouabain-dependent cell shortening in adult rat cardiomyocytes

Retroviral infection and selection of culture-derived platelets allows study of the effect of transgenes on platelet physiology ex vivo and on thrombus formation in vivo

The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times

Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance

Myocardial Technetium-99m-Tetrofosmin and Technetium-99m-Sestamibi Kinetics in Normal Subjects and Patients with Coronary Artery Disease

Increased expression of isoform 1 of the sarcoplasmic reticulum Ca(2+)-release channel in failing human heart

SERCA2a activity correlates with the force-frequency relationship in human myocardium

The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia

Cyclic Peptides for Effective Treatment in a Long-Term Model of Graves Disease and Orbitopathy in Female Mice

Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells

Prolonged TSH Receptor A Subunit Immunization of Female Mice Leads to a Long-Term Model of Graves' Disease, Tachycardia, and Cardiac Hypertrophy

Impact of glycoprotein VI and platelet adhesion on atherosclerosis—A possible role of fibronectin

The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR -/- /ApoBec -/- Mice

ADPase CD39 Fused to Glycoprotein VI‐Fc Boosts Local Antithrombotic Effects at Vascular Lesions

The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemiaa

Effect of the oxLDL Binding Protein Fc-CD68 on Plaque Extension and Vulnerability in Atherosclerosis

PET/CT and MR imaging biomarker of lipid-rich plaques using [64 Cu]-labeled scavenger receptor (CD68-Fc)

Suchergebnisse filtern